OncoPharm
OncoPharm
John Bossaer
Mirvetuximab Soravtansine
19 minutes Posted Nov 17, 2022 at 4:47 pm.
0:00
19:29
Download MP3
Show notes
A new antibody-drug conjugate is approved for ovarian cancer.